Ceretas Limited (ABN 15 681 662 224) Level 4 348 Edward St Brisbane QLD 4000 Australia +61 7 3543 4424 | [email protected] | www.ceretas.com.au ASX Announcement Ethics Committee Approval Secured for Additional CERE-CALM Trial Sites § St Vincent’s Hospital Sydney Human...
Ethics Committee Approval Secured for Additional Trial Sites
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Ceretas
- Appendix 4G
- Corporate Governance Statement
- Appendix 4E & Annual Report 30 June 2026
- Change of Address
- Investor Presentation
Later from Ceretas
- Milestone 3 Completed for CUREator Program
- Date of AGM and Closing Date for Director Nominations
- Investor Presentation - October 2026
- Notice of Annual General Meeting/Proxy Form
- First Patient Enrolled in Phase 2 CERE-CALM Clinical Trial
Follow Ceretas into a list and get an email when it puts out news.
Follow Ceretas